FDA to reportedly expand booster eligibility to those between 12 and 15 next week


The U.S. Food and Drug Administration is reportedly set to authorize COVID-19 booster shots for those between the ages of 12 and 15.
The FDA will expand eligibility for Pfizer booster doses to this age group on Monday, The New York Times reported, citing sources familiar with the agency's planning. This would reportedly be followed by a meeting of a Centers for Disease Control and Prevention advisory committee in the middle of the week to decide whether to recommend the authorization. CNN also reported the FDA will make this move "in the coming days."
Additionally, the Times reports that regulators "plan to allow both adolescents and adults to seek an extra shot of Pfizer's vaccine five months after receiving a second dose," down from six months, and will also authorize boosters for kids between 5 and 11 who have immune deficiencies. This will come as the United States grapples with new daily records for the number of COVID-19 cases amid the spread of the contagious Omicron variant. The FDA expanded Pfizer booster dose eligibility to 16-year-olds and 17-year-olds earlier this month.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I strongly encourage adolescents ages 16 and 17 to get their booster if they are at least 6 months post their initial Pfizer vaccination series," CDC Director Rochelle Walensky said at the time.
Walensky previously told CNN this week that the FDA was looking at expanding booster eligibility to those between 12 and 15. "The FDA is looking at that right now," she said. "Of course, the CDC will swiftly follow as soon as we hear from them, and I'm hoping to have that in the days to weeks ahead."
The CDC director also told CNN that "companies and manufacturers are working towards data" on vaccines for children under five but that this will "not be in the month ahead."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Labubu: the 'creepy' dolls sparking brawls in the shops
Craze for the pint-sized soft toys has reached fever pitch among devotees
-
The top period dramas to stream now
The Week Recommends Heaving bosoms and billowing shirts are standard fare in these historical TV classics
-
Women need more pain management during gynecological procedures
Under the radar Pain should no longer be ignored
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia